Biocorrx (BICX) Expected to Announce Earnings on Monday

Posted by on Mar 29th, 2026

Biocorrx (OTCMKTS:BICX – Get Free Report) is expected to issue its resultson Monday, March 30th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $0.22 million for the quarter.

Biocorrx Price Performance

Shares of OTCMKTS BICX opened at $0.40 on Friday. The stock’s 50-day moving average is $0.35 and its two-hundred day moving average is $0.36. Biocorrx has a 1-year low of $0.20 and a 1-year high of $0.50. The company has a market cap of $10.56 million, a price-to-earnings ratio of -1.25 and a beta of 0.33.

About Biocorrx

(Get Free Report)

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.

Featured Stories

Earnings History for Biocorrx (OTCMKTS:BICX)

Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.